Genetic Signatures Limited (GSS.AX)
ASX - ASX Delayed price. Currency in AUD
Add to watchlist
At close: 02:33PM AEST
| Previous close | 0.7600 |
| Open | 0.7600 |
| Bid | 0.7400 x 0 |
| Ask | 0.7600 x 0 |
| Day's range | 0.7500 - 0.7600 |
| 52-week range | 0.3800 - 0.8500 |
| Volume | |
| Avg. volume | 197,589 |
| Market cap | 169.929M |
| Beta (5Y monthly) | 0.04 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.1200 |
| Earnings date | 28 Aug 2024 - 01 Sept 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 1.10 |
Simply Wall St.Several Insiders Invested In Genetic Signatures Flagging Positive News
When a single insider purchases stock, it is typically not a major deal. However, when multiple insiders purchase...
- Simply Wall St.
Genetic Signatures Limited (ASX:GSS) is definitely on the radar of institutional investors who own 44% of the company
Key Insights Given the large stake in the stock by institutions, Genetic Signatures' stock price might be vulnerable to...
PR NewswireFDA Clearance For Gastrointestinal Parasite Detection Kit
Genetic Signatures Limited [ASX:GSS] ("GSS" or the "Company"), a global molecular diagnostics company announces that the US Food & Drug Administration ("FDA") has cleared the Company's EasyScreen™ Gastrointestinal Parasite Detection Kit and GS1 automated workflow[1] for marketing and sale in the US.
© 2024 Yahoo. All rights reserved.